Response to Letter to Editor " V617F Mutation in Cervical Cancer Related to HPV & STIs" by Stephen E. Langabeer.
作者信息
Sohrabi Amir
机构信息
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
出版信息
J Cancer Prev. 2019 Mar;24(1):61-62. doi: 10.15430/JCP.2019.24.1.61. Epub 2019 Mar 30.
Abstract
摘要
相似文献
1
Response to Letter to Editor " V617F Mutation in Cervical Cancer Related to HPV & STIs" by Stephen E. Langabeer.对斯蒂芬·E·兰加比尔所写的致编辑的信《宫颈癌中与HPV和性传播感染相关的V617F突变》的回复
J Cancer Prev. 2019 Mar;24(1):61-62. doi: 10.15430/JCP.2019.24.1.61. Epub 2019 Mar 30.
2
" V617F Mutation in Cervical Cancer Related to HPV & STIs" - Letter.“与HPV和性传播感染相关的宫颈癌中的V617F突变”——信函
J Cancer Prev. 2019 Mar;24(1):59-60. doi: 10.15430/JCP.2019.24.1.59. Epub 2019 Mar 30.
3
Characterization of JAK2 V617F (1849 G > T) Mutation in Cervical Cancer Related to Human Papillomavirus and Sexually Transmitted Infections.人乳头瘤病毒和性传播感染相关宫颈癌中JAK2 V617F（1849G>T）突变的特征分析
J Cancer Prev. 2018 Jun;23(2):82-86. doi: 10.15430/JCP.2018.23.2.82. Epub 2018 Jun 30.
4
Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population.人群中 49488 例个体 JAK2 V617F 体细胞突变对骨髓增殖性肿瘤的诊断价值。
Br J Haematol. 2013 Jan;160(1):70-9. doi: 10.1111/bjh.12099. Epub 2012 Nov 1.
5
Is Low Positive JAK2 V617F Mutation Test Result Clinically Significant?: Multi-Institutional Study.
Appl Immunohistochem Mol Morphol. 2016 Sep;24(8):589-94. doi: 10.1097/PAI.0000000000000228.
6
Ectopic PD-L1 expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated via increased activation of STAT3 and STAT5.JAK2（V617F）骨髓增殖性肿瘤患者中 PD-L1 的异位表达是通过 STAT3 和 STAT5 的激活增加介导的。
Hum Cell. 2020 Oct;33(4):1099-1111. doi: 10.1007/s13577-020-00370-6. Epub 2020 Jul 14.
7
Frequency of JAK2 V617F mutation in patients with Philadelphia positive Chronic Myeloid Leukemia in Pakistan.在巴基斯坦，费城阳性慢性髓性白血病患者中 JAK2 V617F 突变的频率。
Pak J Med Sci. 2014 Jan;30(1):185-8. doi: 10.12669/pjms.301.3906.
8
Frequency and characteristics of the V617F mutation in 23 cerebral venous sinus thrombosis patients with thrombocytosis.23 例伴有血小板增多的脑静脉窦血栓形成患者 V617F 突变的频率和特征。
J Int Med Res. 2020 Dec;48(12):300060520977729. doi: 10.1177/0300060520977729.
9
Sex modulation of the occurrence of jak2 v617f mutation in patients with splanchnic venous thrombosis.性别的调节对肠系膜静脉血栓形成患者 jak2 v617f 突变发生的影响。
Thromb Res. 2011 Sep;128(3):233-6. doi: 10.1016/j.thromres.2011.03.024. Epub 2011 Apr 16.
10
CRISPR/Cas12a-Based Ultrasensitive and Rapid Detection of V617F Somatic Mutation in Myeloproliferative Neoplasms.基于 CRISPR/Cas12a 的超灵敏快速检测骨髓增殖性肿瘤中的 V617F 体细胞突变。
Biosensors (Basel). 2021 Jul 24;11(8):247. doi: 10.3390/bios11080247.
引用本文的文献
1
Trends in cocirculation of oncogenic HPV genotypes in single and multiple infections among the unvaccinated community.未接种疫苗人群中单一感染和多重感染的致癌型 HPV 基因型共循环趋势。
J Med Virol. 2022 Jul;94(7):3376-3385. doi: 10.1002/jmv.27706. Epub 2022 Mar 24.
本文引用的文献
1
" V617F Mutation in Cervical Cancer Related to HPV & STIs" - Letter.“与HPV和性传播感染相关的宫颈癌中的V617F突变”——信函
J Cancer Prev. 2019 Mar;24(1):59-60. doi: 10.15430/JCP.2019.24.1.59. Epub 2019 Mar 30.
2
Characterization of JAK2 V617F (1849 G > T) Mutation in Cervical Cancer Related to Human Papillomavirus and Sexually Transmitted Infections.人乳头瘤病毒和性传播感染相关宫颈癌中JAK2 V617F（1849G>T）突变的特征分析
J Cancer Prev. 2018 Jun;23(2):82-86. doi: 10.15430/JCP.2018.23.2.82. Epub 2018 Jun 30.
3
Comparative study of different methodologies to detect the V617F mutation in chronic BCR-ABL1 negative myeloproliferative neoplasms.检测慢性BCR-ABL1阴性骨髓增殖性肿瘤中V617F突变的不同方法的比较研究
Pract Lab Med. 2015 Dec 14;4:30-37. doi: 10.1016/j.plabm.2015.12.004. eCollection 2016 Apr 1.
4
Polymorphisms in immune mediators associate with risk of cervical cancer.免疫介质中的多态性与宫颈癌风险相关。
Gynecol Oncol. 2014 Oct;135(1):69-73. doi: 10.1016/j.ygyno.2014.07.106. Epub 2014 Aug 12.
5
The JAK2 exon 12 mutations: a comprehensive review.JAK2 外显子 12 突变：全面综述。
Am J Hematol. 2011 Aug;86(8):668-76. doi: 10.1002/ajh.22063. Epub 2011 Jun 14.
Zotero 插件